Figure 5
From: Circulating miR-19b and miR-181b are potential biomarkers for diabetic cardiomyopathy
Circulating miRNAs in plasma at 16 months. MiRNAs were assessed at 16 months of dietary treatment. Relative abundance of each miRNA was normalized to cel-miR-39. (n = 8–9). Mean ± SEM, *p < 0.05, **p < 0.01 vs. normal mice (Mann-Whitney test).
